These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10929482)
41. Management of hypercholesterolaemia in the patient with diabetes. Packard C; Olsson AG Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606 [TBL] [Abstract][Full Text] [Related]
42. [Measurement of apolipoproteins is better than routinely measured traditional lipids]. Kallner A; Estonius M Lakartidningen; 2006 Mar 8-14; 103(10):753-6, 758. PubMed ID: 16610202 [No Abstract] [Full Text] [Related]
43. Coronary risk factors. Pearson TA Med Sect Proc; 1986; ():33-46. PubMed ID: 3601936 [No Abstract] [Full Text] [Related]
44. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol. Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508 [TBL] [Abstract][Full Text] [Related]
45. What is the most effective strategy for managing diabetic dyslipidaemia? Reasner CA Atheroscler Suppl; 2005 Sep; 6(3):21-7. PubMed ID: 16054442 [TBL] [Abstract][Full Text] [Related]
46. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort. Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952 [TBL] [Abstract][Full Text] [Related]
47. Cardiovascular risk factors in people older than 65. Doram KR; Wise GR West J Med; 1992 Jan; 156(1):70. PubMed ID: 1734605 [No Abstract] [Full Text] [Related]
48. Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices. Walsh MN; Simpson RJ; Wan GJ; Weiss TW; Alexander CM; Markson LE; Berger ML; Pearson TA Am J Manag Care; 2002 Nov; 8(11):937-46. PubMed ID: 12437309 [TBL] [Abstract][Full Text] [Related]
49. Focus on cardiac care at AACC '01. Stevenson R; Am Clin Lab; 2001; 20(9):6, 8, 10. PubMed ID: 11766420 [No Abstract] [Full Text] [Related]
50. High blood cholesterol. National Heart, Lung and Blood Institute Nutr Clin Care; 2003; 6(3):108-14. PubMed ID: 14979453 [TBL] [Abstract][Full Text] [Related]
51. LDL-apheresis: indications and clinical experience in a tertiary cardiac centre. Archontakis S; Pottle A; Hakim N; Ilsley C; Barbir M Int J Clin Pract; 2007 Nov; 61(11):1834-42. PubMed ID: 17935547 [TBL] [Abstract][Full Text] [Related]
52. Dyslipidemia and coronary heart disease: management issues from Indian perspective. Gambhir DS; Gambhir JK; Sudha R Indian Heart J; 2000; 52(5):515-6, 617. PubMed ID: 11256772 [No Abstract] [Full Text] [Related]
53. Effectiveness of a fenofibrate 145-mg nanoparticle tablet formulation compared with the standard 160-mg tablet in patients with coronary heart disease and dyslipidemia. Maciejewski S; Hilleman D Pharmacotherapy; 2008 May; 28(5):570-5. PubMed ID: 18447655 [TBL] [Abstract][Full Text] [Related]
54. Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? Karp I; Abrahamowicz M; Fortin PR; Pilote L; Neville C; Pineau CA; Esdaile JM Arthritis Rheum; 2008 Feb; 59(2):169-75. PubMed ID: 18240259 [TBL] [Abstract][Full Text] [Related]
55. Beyond LDL-cholesterol: can further reductions in CAD risk be achieved by considering triglycerides? Davignon J; Pearson TA Can J Cardiol; 1998 May; 14 Suppl B():2B. PubMed ID: 9627534 [No Abstract] [Full Text] [Related]